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ABSTRACT: 
Purpose: 
The purpose of this study was to assess the feasibility of using an existing computer decision support system 
(CDSS) to screen adolescent patients for suicidality and provide follow-up guidance to clinicians in a primary 
care setting. Predictors of patient endorsement of suicidality and provider documentation of follow-up were 
examined. 
Methods: 
A prospective cohort study was conducted to examine the implementation of a CDSS that screened adolescent 
patients for suicidality and provided follow-up recommendations to providers. The intervention was 
implemented for patients aged 12-20 years in two primary care clinics in Indianapolis, Indiana.   
Results: 
The sample included 2,134 adolescent patients [51% female; 60% Black; mean age=14.6 years (SD=2.1)]. Just 
over 6% of patients screened positive for suicidality. A positive endorsement of suicidality was more common 
among patients who were female, depressed, and seen by an adolescent medicine board certified provider as 
opposed to general pediatric provider. Providers documented follow-up action for 83% of patients who screened 
positive for suicidality. Documentation of follow-up action was correlated with clinic site and Hispanic race. 
The majority of patients who endorsed suicidality (71%) were deemed not actively suicidal after assessment by 
their provider. 
Conclusions: 
Incorporating adolescent suicide screening and provider follow-up guidance into an existing CDSS in primary 
care is feasible and well utilized by providers. Female gender and depressive symptoms are consistently 
associated with suicidality among adolescents, although not all suicidal adolescents are depressed. Universal 
use of a multi-item suicide screener that assesses recency might more effectively identify suicidal adolescents. 
Keywords: Adolescent, Suicide, Screening, Primary Care, CDSS 
Implications and Contribution: Computer decision support systems (CDSS) can be used effectively in primary 
care to screen adolescents for suicidality and provide follow-up recommendations for providers. Female gender, 
younger age, and depressive symptoms were associated with lifetime suicidality among adolescents, although 
not all suicidal adolescents reported depressive symptoms.  
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Suicide is the second leading cause of death among adolescents aged 10 to 19, with over 2,200 suicide-
related deaths recorded in that age group in 2014 [1]. Moreover, the rate of adolescent suicide shows no signs of 
decreasing. From 2007 to 2015, the suicide rate among males aged 15 to 19 increased 31%, and among females, 
it doubled, reaching the highest rate recorded for the period 1975-2015 [2]. In 2015, about 9% of high school 
students (grades 9-12) reported attempting suicide and about 3% reported having made an attempt that required 
medical intervention [3]. Other suicide-related behaviors such as suicidal ideation and making a plan to commit 
suicide are also increasingly prevalent among US adolescents. In 2015, over 17% of high school students 
reported having seriously considered attempting suicide and over 14% reported having made a plan to commit 
suicide [3].  
Most adolescents visit a primary care provider at least once a year [4]. Although some adolescents are 
not engaged in primary care [5], the primary care visit represents an opportunity to conduct suicide screening 
and intervention for those who are. However, most primary care providers do not screen adolescents for suicide 
risk, perhaps due to it being a low base rate event, [6, 7] a lack of formal psychiatric training, and/or a general 
uncomfortableness screening adolescent patients for suicide risk [6]. Regardless of the reason, as many as 83% 
of adolescent suicide attempters are not identified as such by their primary care providers [6]. One method of 
increasing rates of suicide risk screening among adolescents is to standardize the screening process. 
Interventions that introduce standardized suicide risk screening questions into already-existing electronic 
medical record questionnaires have demonstrated feasibility [8] and achieved increased rates of screening for, 
detection of, and referral for suicidality [9] among adolescent patient populations. While several studies have 
examined the feasibility of suicide screening in primary care, none has examined how electronic suicide risk 
screening can also be used to inform specific provider follow-up actions. 
Despite evidence that increased screening practices lead to increased rates of detection and treatment, 
recommendations for adolescent suicide screening in primary care are inconsistent. The American Academy of 
Pediatrics and the American Medical Association recommend annual suicide screening for adolescents in 
primary care [10-13]. The U.S. Preventative Services Task Force, however, concluded that there is insufficient 
evidence to recommend universal screening for suicide risk among asymptomatic adolescents and adults [14]. 
The present study assesses the use of a computerized clinical decision support system (CDSS) to screen 
adolescents for suicide risk, deliver follow-up recommendations to the provider, and document actual provider 
follow-up actions in a primary care setting.  
Methods 
CHICA System Overview  
The Child Health Improvement through Computer Automation (CHICA) System is a CDSS that 
integrates electronic medical record (EMR) system data, pre-visit screening data and correlative provider 
responses from previous visits to generate appropriate follow-up recommendations, tools, and provider prompts. 
When a patient checks into a clinic, the CHICA system automatically generates a pre-visit screener form (PSF) 
based on information in the patient’s EMR including age, developmental stage, current and previous medical 
conditions, and known risk factors for morbidity. The PSF is administered on an electronic tablet and is 
completed prior to the provider encounter. It consists of two parts: 1) a form for the nurse to record vitals, 
height, and weight; and 2) a 20-item patient questionnaire on a variety of health-related topics such as diet, 
depression, sexual behaviors, and substance use.  
A provider worksheet (PWS) is generated based on patient responses to PSF items. Partially completed 
PSFs still generate a PWS. The PWS is printed and given to the provider for consultation during the encounter. 
It consists of six prompts, each identifying a health need based on patient responses to the PSF questionnaire or 
information in the EMR. The prompts are prioritized by the CHICA system based on national clinical 
guidelines and a decision analytic algorithm [15]. Each prompt consists of an explanation of the health need 
followed by corresponding action items, each with a checkbox, that allow the provider to document data, 
procedures, prescriptions, referrals, and other actions that might take place during the encounter. Figure 1 
displays the provider prompt that is generated when a patient endorses suicidality. Providers may select more 
than one follow-up option for the suicide prompt; in fact, the first action (“high risk for suicide”) is followed by 
an arrow to indicate that an additional follow-up action is warranted.  
When a provider responds to worksheet prompts, the form is scanned and uploaded by clinic staff after 
the patient encounter. The CHICA system analyzes provider responses using optimal mark and character 
recognition to detect which action items were taken by the provider and then records the appropriate actions in a 
database. Together, the PSF and PWS provide screening and correlative follow-up options for providers. More 
detailed information about CHICA including rule processing, development of Arden rules, data storage, and 
implementation can be found in previous publications [16-19].  
Study Design and Screening Process  
Adolescents aged 12-20 who presented to their pediatric primary care clinic for an annual (non-sick) or 
sick visit were selected to participate in the controlled trial. The suicide screening tool was implemented in two 
primary care federally qualified health center clinics that utilize CHICA and are part of an urban, Midwest 
county hospital system (Eskenazi Health).  Providers were primarily trained in pediatrics, family medicine, and 
combined internal medicine and pediatrics, with some having completed subspecialty fellowship training in 
adolescent medicine. Many clinic visits occurred during adolescent-specific clinic times. IRB approval was 
received from the local university.  
Study Variables 
 Suicide risk was assessed on the PSF using a single question based on AAP and AMA recommendations 
[10, 11, 13]: “Have you ever seriously thought about killing yourself, made a plan, or actually tried to kill 
yourself?”  In addition to suicide risk, depression was also assessed as part of the PSF using the Patient Health 
Questionnaire-2 (PHQ-2) [20] as an initial screen. This instrument consists of two questions assessing 
anhedonia and depressed mood over the past two weeks. If the adolescent responded “yes” to one or both 
questions in the PHQ-2, the Patient Health Questionnaire-9 (PHQ-9), a longer nine-item screening tool for 
depression [21], was automatically administered. The PHQ-2 and PHQ-9 have sensitivities of 74% and 96% 
and specificities of 75% and 82% respectively [20, 21].  
Adolescent substance use was assessed according to the American Academy of Pediatrics’ Bright 
Futures guidelines [22], which recommend a two-part screening process. The first part consists of a three-item 
pre-screener, which asks the patient about drinking alcohol, smoking marijuana or hashish, and using anything 
else to get high during the past twelve months. A positive response to any item triggers a longer six-item 
measure called the CRAFFT [22, 23].  For the purposes of this study, if the patient answered “yes” to any of the 
three pre-screener questions about substance abuse, they were categorized as having used substances in the past 
twelve months. 
Chart Abstraction 
Data indicated by providers on PWS prompts were captured by the CHICA system through optimal 
mark recognition. However, in some cases, the provider did not indicate a response to a PWS suicide prompt. In 
cases where a patient screened positive for suicide and no provider action was documented on the PWS, a chart 
review was conducted by trained research assistants to review manually entered provider notes to find 
indications of follow-up action. Thirty percent of cases included in the chart abstraction were audited by a 
second research assistant with a pooled kappa of κ=0.79, which indicates substantial agreement [24]. Data 
acquired during the chart abstraction were incorporated into the CHICA-generated dataset. 
Analyses 
 Descriptive statistics [means and standard deviations (SD), frequencies] were calculated for patient 
demographic characteristics, clinic site, provider type (general pediatric (GP) or adolescent medicine board 
certified (AMBC)), suicidality endorsement, substance use endorsement, and endorsement of depressive 
symptoms on the PHQ-2.  Descriptive statistics were calculated for provider follow-up actions at the patient’s 
first visit with suicide risk endorsement.  For never suicidal patients, provider follow-up actions were drawn 
from the first overall visit during the study time frame. 
We then calculated the prevalence of suicidality and described provider follow-up treatment practices. 
Fisher’s exact tests were performed to determine the extent to which certain demographic and clinical factors 
were associated with patient endorsement of suicidality. Lastly, two predictive models were conducted to model 
(1) adolescent endorsement of suicidality on the entire patient population (N=2130) and (2) provider follow-up 
practices on patients who screened positive for suicidality (N=131). Logistic regression analysis was performed 
for model (1). Mixed effects logistic regression analysis was performed for model (2) to account for the 
clustering among patients’ follow-up practices within providers. For both models, we performed internal 
validation by splitting the data into training and validation datasets. We then used receiver operating 
characteristic (ROC) curve and area under the ROC curve (AUC) to assess the validity of the model. The model 
was fit using the training data set and then assessed by applying the model to the validation data set.   
Results 
 Our sample population included 2,134 adolescents [51% female; 60% Black; mean age=14.6 years 
(SD=2.1)] who presented to a primary care provider for either a sick visit or non-sick visit during the study 
period and who completed a PSF. Table 1 contains demographic information for the overall patient sample as 
well as for the subset that endorsed suicidality. Just over 6% of patients (n=131) endorsed suicidality. Table 2 
displays the results of a univariate analysis of patient demographic and clinical factors on suicidality. Based on 
these results, patients who were female, patients who reported depressive symptoms, and patients who were 
seen by an AMBC provider (as opposed to a GP provider) were more likely to report suicidality. Substance use 
was also associated with suicidality but with borderline significance.  There were no known suicide attempts 
during the study period. 
Initially, 32% (n=42) of records with a positive suicide screen were lacking documentation of provider 
follow-up action on the PWS. Subsequent chart review and visual review of the PWS, however, decreased this 
number by 20 records. Of those 20 records, five were found on chart review to indicate provider action on the 
PWS that had not been recorded in the CHICA system due to either a misplaced check mark or scanning error. 
The remaining 15 were found to indicate follow-up action by the provider in the provider note, which is 
manually entered into the chart and not part of the automated CHICA system. In the end, providers failed to 
document follow-up for 22 adolescents who endorsed suicidality (17%). 
 Provider follow-up actions to positive suicide screens are detailed in Table 3. Of the 131 patients who 
endorsed suicidality, 22 cases (17%) were lacking documentation of provider follow-up and 93 (71%) were 
deemed “not suicidal” after assessment by the provider. Of the remaining 16 patients (12%) who endorsed 
suicidality, there were 13 instances of the provider selecting “high risk for suicide”, 10 instances of immediate 
hospitalization and psychiatric evaluation, 9 referrals to a crisis center, and 12 referrals to a suicide prevention 
handout.  Importantly, providers could select more than one follow-up action for any given patient. Overall, 
providers documented follow-up for 83% of patients who endorsed suicidality. Clinic site and Hispanic race 
were both highly correlated with documentation of provider follow-up as all Hispanic patients and all patients 
seen at clinic site B received documented follow-up from their provider. 
 A multivariable logistic regression analysis was conducted to model predictors of suicidality on the 
entire patient population (N=2130).  Variables included in this analysis were the same as those included in the 
univariate analysis. Significant predictors of suicidality included female gender [OR 3.17 (1.81, 5.53); p<0.01] 
and depressive symptoms as measured by the PHQ-2 [OR 16.66 (9.66, 28.71); p<0.01].  A second mixed effects 
multivariable logistic regression analysis was conducted to model predictors of provider follow-up on patients 
who endorsed suicidality (N=131). Variables included gender, race, age group, provider type, substance use and 
depression. Clinic site was excluded from this analysis because it separated the outcome variable as mentioned 
previously. According to this model, there were no significant predictors of provider follow-up. For both 
predictive models, the area underneath the curve (AUC) was calculated to summarize their diagnostic accuracy. 
An AUC of 0.5 indicates no discrimination and 1.0 indicates perfect discrimination [25]. For the first model, the 
area under the curve (AUC) was 0.86 for the training dataset and 0.84 for the validation dataset. For the second 
model, the area under the curve (AUC) was 0.74 for the training dataset and 0.72 for the validation dataset. 
Discussion 
Suicide is a significant source of morbidity and mortality among adolescents [13].  Primary care is an 
ideal setting in which to identify and intervene with suicidal adolescents. Consistent with prior work, this study 
demonstrates implementation of a suicide screening algorithm into an existing CDSS to screen a large number 
of adolescents for suicidality as part of routine primary care.  Though other studies have examined predictors of 
adolescent suicidality in community samples, the current study contributes to the literature in that it is one of 
only two studies to examine predictors of positive suicide screening in primary care settings.   
Epidemiology of Adolescent Suicidality 
The rate of adolescent suicidality in the current study (6%) was similar to the rates in previous studies, 
suggesting that the suicide screening procedures in this study were effective in identifying adolescents with a 
history of suicidality. Two prior studies reported slightly lower rates of suicidality than the current study. Using 
face-to-face provider screening, Wintersteen [9] found that 3.6% of all adolescents endorsed lifetime suicidal 
thoughts or behaviors but reported no differences based on demographic characteristics. Using computerized 
assessments, Husky, et al. [26] found that 4.6% of adolescents reported current suicidal thoughts or previous 
suicide attempts with no significant differences based on gender, age, or race. In contrast, Gardner, et al. [8] 
identified higher rates with 14% of primary care adolescents reporting suicidal thoughts in the past month on 
tablet-based screenings.  
 In national surveys, adolescents recruited from community settings have typically reported higher rates 
of suicidality than those screened in primary care settings  In 2015, the Youth Risk Behavior Survey [3] found 
that 17% of adolescents reported seriously considering attempting suicide in the past 12 months, and the 
National Comorbidity Survey [27] found that 12% of youth endorsed lifetime suicidal ideation.  One possible 
explanation for a difference in rates of adolescent suicidality between community and clinical settings is that 
community surveys are often anonymous and participants may perceive that there will be no consequences for 
reporting suicidality.  In a clinical setting, however, patients understand that their provider will see their 
responses, which may decrease the likelihood of them endorsing suicidality [9]. Another possible explanation is 
that many high-risk adolescents are not engaged in primary care [28].   
Screening and Follow-Up 
According to AAP guidelines [13], adolescents who report ever considering suicide on a screening tool 
should be assessed by a healthcare provider.  We demonstrated that electronic patient screening followed by 
action prompts for healthcare providers is both feasible and well utilized. Providers documented follow-up for 
83% of adolescent patients who endorsed suicidality. Of those patients, the majority (71%) were deemed not 
suicidal.  Providers failed to document follow-up in 17% of cases with a positive endorsement of suicidality. 
However, lack of documentation does not necessarily mean the patient didn’t receive follow-up attention. Upon 
chart review, documentation of follow-up action was found elsewhere in the chart for almost half of records that 
were initially missing it. Even so, lack of documented follow-up is both a clinical and legal problem with 
implications beyond the scope of this discussion (see Goodman, 2016 [29] for a thorough discussion of the 
ethical issues of CDSS). In an effort to increase compliance with follow-up guidelines, study investigators 
implemented an emergency response system by which clinic directors received an email if no follow-up action 
was documented within 24 hours of an encounter involving a positive suicide screen. This system was recently 
implemented and the authors cannot speak to its effectiveness at this time.  
Risk Factors and Co-Morbidity 
Depression is widely recognized as a risk factor for suicide [30], with many studies establishing suicide 
and depression as co-outcomes [31, 32] or using depressive symptoms as a selection criterion for suicide risk 
screening [33-37]. Many providers may view suicidality as a problem that occurs only in individuals with 
psychiatric disorders [9]. The current study identified depression as a strong predictor of suicidality; however, 
our results suggest that suicide risk and depression do not always co-occur.  In fact, 24% of adolescents who 
endorsed suicidality did not report depressive symptoms and one of those adolescents was deemed currently 
suicidal by their provider.  Thus, using depressive symptoms as a selection criterion for suicide screening is 
generally warranted but may result in missed opportunities for identification, intervention and treatment of 
suicidality. Primary care providers should consider universal, independent screenings for both depression and 
suicidality.  
Substance use is another risk factor often associated with suicidality in adolescent populations. In the 
current study, substance use was weakly associated with suicidality (p=0.07) in univariate analysis, but other 
studies report stronger correlations. More specifically, substance abuse disorder diagnoses [38], alcohol use [27, 
34, 39], marijuana use [39], and illicit drug use [27] have all been associated with an increased risk for 
suicidality in adolescent populations. Adolescents with dual diagnoses of depression and substance use are at an 
even higher risk for suicide [36]. Based on this information, there is a strong case for primary care providers to 
screen for both depression and substance use among adolescent patients.  
Limitations  
 One limitation of the current study is that is doesn’t assess recency of suicidality. A multi-item screening 
tool that assesses recency could provide more detailed information about the urgency and nature of suicide risk, 
allowing for more tailored follow-up recommendations for the provider.  However, the desire for more 
information must be balanced with clinic-flow and time constraints. The single-item tool used in this study is 
the item recommended by Bright Futures [40], and as there is a need to assess multiple risk areas in primary 
care, a single item measure of suicide is feasible to implement in the primary care setting. A strength of CDSS 
is that a general single-item measure can be administered universally in primary care, and a brief, multi-item 
follow-up screen can then be administered to further define risk and guide provider action.  
Several adolescents who endorsed suicidality appeared to receive no follow-up from their provider as 
suggested by a lack of documentation on the PWS. Although chart reviews were helpful in identifying 
documentation of provider follow-up outside of the CHICA system, it cannot be determined in these cases 
whether or not the CDSS and associated prompts influenced the provider’s behavior. Additionally, this study 
could not assess whether patients actually benefitted from suicide screening procedures or provider follow-up. 
To assess whether patients benefited from provider follow-up would require that data be extracted from visits 
outside of the study encounter, which was defined for each patient as their first visit during the study timeframe 
when they endorsed suicidality, or for patients who never endorsed suicidality, their first visit during the study 
timeframe. This limits our knowledge of both positive and negative outcomes that might have occurred outside 
of the study encounter.  
Finally, it is impossible to know whether the adolescent patient or their caregiver completed the PSF. 
While clinic staff were instructed to hand the tablet computer to the patient and advise that the patient complete 
the questionnaire, it is possible that their caregiver completed it in place of them or with their help. Allowing a 
caregiver to be the informant would likely lead to lower rates of reported suicide, depression, and substance use 
on the screening instrument.  We recommend that future studies include a question that identifies the informant 
as either the patient or someone else.  
Conclusion 
 The current study demonstrated that using a CDSS framework to implement universal suicide screening 
in a pediatric primary care setting is feasible. Of the total sample, 6% of adolescent patients screened positive 
for lifetime suicidality with 10% of those patients determined to be at high risk for attempting suicide after 
provider assessment. The majority of patients who screened positive for suicidality received follow-up from 
their provider.  Depressive symptoms commonly co-occurred with endorsement of lifetime suicidality; 
however, one quarter of patients who endorsed lifetime suicidality did not report depressive symptoms, and one 
of those patients was deemed at high risk for suicide after provider assessment. This suggests that it may be 
beneficial to screen separately and independently for depression and suicide in primary care settings. Further 
research should examine whether integrating a multiple-item suicide screening tool into CDSS would be 
comparably feasible and even more effective in identifying adolescents who are currently experiencing 
suicidality. A multiple item measure would also allow providers to better assess the adolescent’s level of suicide 
risk and tailor follow-up care accordingly.  
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Figure 1. Example Physician Prompt - Suicide 
 
 
 
 
 
** ATTENTION ** [Patient Name] is at risk for suicide: 
SUICIDAL IDEATION OR ATTEMPT – [Date of Positive 
Screen].  Explore symptoms and consequences. 
Identify social support.  
 □ High risk for suicide -> 
□ Immediate hospitalization 
and psych evaluation 
□ Refer to crisis center 
□ Refer to suicide handout  
□ Not suicidal 
Table 1. Patient demographic and clinical factors  
 
 All Patients N=2,130* 
Patients who Endorsed 
Suicidality 
N=131 
                 n                 %                  n                 % 
Race     
   Black 1285 60.3 92 70.2 
   Hispanic 305 14.3 13 9.9 
   Other 374 17.5 15 11.5 
   White 169 7.9 11 8.4 
Gender     
   Female 1088 51.1 101 77.1 
   Male 1042 48.9 30 22.9 
     
Mean Age (SD) 14.6 (2.1) 14.8 (1.9) 
     
Insurance     
Public 1134 53.2 79 60.3 
Private 103 4.8 3 2.3 
Self-pay 148 7.0 6 4.6 
Other 746 35.0 43 32.8 
Clinic type     
General 1803 84.6 103 78.6 
Adolescent  328 15.4 28 21.4 
 
*4 patients excluded due to missing gender 
Table 2. Univariate analysis of patient and clinical factors on suicidality 
 % who endorsed 
suicidality 
Odds ratio (95% CI) P-value 
Gender    
   Female 9.3% 3.45 (2.27, 5.24) <0.01 
    Male 2.9% --- 
Race    
   Black 7.2% 1.11 (0.58, 2.11) 0.08 
   Hispanic 4.3% 0.64 (0.28, 1.46)  
   White 6.5% ---  
   Other 4.0% 0.61 (0.27, 1.35)  
Age group    
Early (12-14) 5.4% --- 0.20 
Middle (15-17) 7.4% 1.39 (0.96, 2.01)  
Late (18-21) 5.5% 1.02 (0.53, 1.98)  
Clinic site    
Clinic A 6.6% --- 0.24 
Clinic B 5.4% 0.80 (0.55, 1.17)  
Provider type    
General pediatric 5.7% --- 0.05 
Adolescent medicine  8.5% 1.54 (1.00, 1.16)  
Substance Use    
Yes 9.4% 1.67 (0.96, 2.88) 0.07 
No 5.9% ---  
Depressive symptoms (PHQ-2)    
Yes 22.4% 15.41 (10.13, 23.44) <0.01 
No 1.8% ---  
 
Table 3. Provider follow-up for adolescents who endorsed suicidality  
Follow-up Items n (%)* 
Deemed high risk for suicide 13 (9.9%) 
Immediate hospitalization and psych evaluation 10 (7.6%) 
Referred to crisis center 9 (6.9%) 
Referred to suicide prevention handout  12 (9.2%) 
Deemed not suicidal 93 (71.0%) 
No documented follow-up 22 (16.8%) 
*Sum of percentages exceeds 100% because more than one follow-up action was indicated for 
some patients. 
